140 related articles for article (PubMed ID: 11747691)
1. Cost-effectiveness of a potential vaccine for Coccidioides immitis.
Barnato AE; Sanders GD; Owens DK
Emerg Infect Dis; 2001; 7(5):797-806. PubMed ID: 11747691
[TBL] [Abstract][Full Text] [Related]
2. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
4. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
Pappagianis D
Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
Rein DB; Hicks KA; Wirth KE; Billah K; Finelli L; Fiore AE; Hoerger TJ; Bell BP; Armstrong GL
Pediatrics; 2007 Jan; 119(1):e12-21. PubMed ID: 17200237
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands.
Meijboom MJ; Rozenbaum MH; Benedictus A; Luytjes W; Kneyber MC; Wilschut JC; Hak E; Postma MJ
Vaccine; 2012 Jun; 30(31):4691-700. PubMed ID: 22561315
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
8. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
9. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of universal pneumococcal vaccination for infants in Italy.
Marchetti M; Colombo GL
Vaccine; 2005 Aug; 23(37):4565-76. PubMed ID: 15992969
[TBL] [Abstract][Full Text] [Related]
13. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
14. Deficient resistance to Coccidioides immitis following intravenous vaccination. II. Evidence against an immune tolerance mechanism.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):90-6. PubMed ID: 4939207
[No Abstract] [Full Text] [Related]
15. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps.
Vold Pepper P; Owens DK
Clin Infect Dis; 2000 Jan; 30(1):157-64. PubMed ID: 10619745
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
[TBL] [Abstract][Full Text] [Related]
18. Deficient resistance to Coccidioides immitis following intravenous vaccination. 3. Humoral and cellular responses to intravenous and intramuscular doses.
Levine HB; Scalarone GM
Sabouraudia; 1971 Jul; 9(2):97-108. PubMed ID: 5111563
[No Abstract] [Full Text] [Related]
19. [The cost-effectiveness of pneumococcal vaccination in Catalonia].
Plans Rubió P; Garrido Morales P; Salleras Sanmartí L
Rev Esp Salud Publica; 1995; 69(5):409-17. PubMed ID: 8564860
[TBL] [Abstract][Full Text] [Related]
20. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
